Septerna Inc Revenue per Employee (SEPN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Septerna Inc   (NASDAQ: SEPN)
 

Septerna Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 22375.63% in the second quarter 2026, year on year to cumulative value of $99 million, Septerna Inc 's revenue per employee grew on a trailing twelve months basis to $ 760,631. The productivity of Septerna Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 155 other companies have achieved higher revenue per employee. While Septerna Inc 's total ranking has deteriorated compared to the previous quarter from 1150 to 1451. Septerna Inc has 130 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SEPN Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 22375.63 % 12010.96 % 11276.42 % 12113.07 % -67.84 %
Sales per Employee (TTM) $ 760,631 555,808 353,469 169,577 5,585
SEPN's Total Ranking # 1451 # 1150 # 2035 # 0 # 0
Seq. Revenue Change 0.84 % 9.97 % 12.2 % 17963.03 % -45.66 %

SEPN Company Profile >> Back to SEPN Efficiency Comparisons >> Compare SEPN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 100
Healthcare Sector # 156
Overall Market # 1451

Revenue per Employee Statistics
High Average Low
$ 555,808 $ 184,860 $ 1,354
(Mar 31 2026)   (Sep 30 2024)



Financial Statements
Septerna Inc 's Revenue MRQ $ 27 Millions Visit SEPN's Income Statement
Septerna Inc 's Revenues TTM $ 99 Millions Visit SEPN's aggregate revenue growth
What are SEPN's Sales? Visit SEPN's Sales by Segment




Other Ratios
Septerna Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SEPN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SEPN's Competitors
Revenue per Employee for SEPN's Suppliers
Revenue per Employee for SEPN's Customers

You may also want to know
SEPN's Sales Growth Rates SEPN's Pe Price to earnings ratio SEPN's Receivables Turnover Ratio SEPN's Stock Quote
SEPN's Net Income Growth Rates SEPN's Ps Price to Sales ratio SEPN's Sales per Employee SEPN's Asset Turnover Ratio
SEPN's Net Margin SEPN's Pb Price to Book ratio SEPN's Financial Strength Ratios SEPN's Dividend Payout Ratio
Date modified: 2026-08-31T18:03:29+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Akebia Therapeutics Inc   1,129,175.26 $ 219.060  Million 194 
Siga Technologies Inc  1,095,079.92 $ 53.659  Million 49 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million 8 
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Evolus Inc   949,440.12 $ 317.113  Million 334 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
Ardelyx inc   922,073.62 $ 450.894  Million 489 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 
Pacira Biosciences inc   900,077.20 $ 746.164  Million 829 
Fortress Biotech Inc   897,217.95 $ 69.983  Million 78 
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Verastem Inc   858,098.04 $ 87.526  Million 102 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.